Stock Quote
Northstar Neuroscience, Inc. (NSTR.OQ) (NASDAQ Stock Exchange Global Market)
$0.08
24 Nov 2009
+0.00%
$0.08
--
8,200
$0.08
$0.08
$2.17
$0.05
0.23
3,669
NSTR.OQ
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Levy, Alan | Chairman of the Board | 387,492 |
| Dow, Brian | Chief Financial Officer, Vice President - Finance, Secretary | 228,874 |
| Gani, Matthew | Vice President - Product Development | 290,386 |
Profile
Northstar Neuroscience, Inc. is a development-stage medical device company focused on developing and commercializing neuromodulation therapies to restore function and quality of life for people suffering from neurological diseases and disorders. The Renova Cortical Stimulation System is designed to... Full Description
Company Address
Northstar Neuroscience, Inc.
2401 Fourth Avenue
Suite 300
Seattle WA 98121
P: +1206.3000204
2401 Fourth Avenue
Suite 300
Seattle WA 98121
P: +1206.3000204
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Cyberonics, Inc. | $17.87 | -0.67 |
| Medtronic, Inc. | $42.99 | -0.19 |
| St. Jude Medical, Inc. | $36.41 | -0.38 |
| NSTR.OQ | Industry | |
|---|---|---|
| P/E(TTM) | -- | 8.26 |
| P/S(TTM) | -- | 0.54 |
| ROI(TTM) | -32.56 | 1.17 |
| ROE(TTM) | -32.67 | 1.71 |
| Consensus Recommendation | |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $0.00M |
| Net Income | $-8.90M |
| EPS | $-0.34 |
